Ganesan Venkatasubramanian | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2384

Journal of Addiction Research & Therapy received 2384 citations as per google scholar report

Journal of Addiction Research & Therapy peer review process verified at publons
Indexed In
  • CAS Source Index (CASSI)
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • SafetyLit
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Ganesan Venkatasubramanian

Department of Psychiatry, National Institute of Mental Health and Neuro Sciences [NIMHANS], Bangalore, India


Ganesan Venkatasubramanian is psychiatrist by training & currently he work as an additional professor of psychiatry at the Department of Psychiatry at National Institute of Mental Health and Neuro Sciences [NIMHANS], Bangalore, India.
Research Interest
Schizophrenia is complex neuropsychiatric disorder is characterized by delusions, hallucinations, disorganized behaviour and progressive cognitive deficits, whose pathophysiology remains unclear. It is ranked among the top ten disabling disorders by the World Health Organization. A compelling hypothesis with translational potential, investigated in the senior fellowship research, is that “complex interactions between neuroimmunological / neutrophic factors and hippocampus might underlie the pathogenesis of schizophrenia”. Ascertaining evidence for these pathogenetic interactions will enhance our understanding of this intriguing disorder and can potentially open novel therapeutic targets for schizophrenia.